Centre for Policy on Ageing
 

 

Consultant pharmacist drug therapy interventions in a geriatric nursing facility
 — a one-year study
Author(s)James W Cooper
Journal titleJournal of Geriatric Drug Therapy, vol 11, no 4, 1997
Pagespp 51-63
SourceHaworth Document Delivery Center, The Haworth Press Inc., 10 Alice Street, Binghamton, NY 13904-1580, USA.
KeywordsDrugs ; Long term patients ; Costs [care] ; United States of America.
AnnotationIn this US study of 182 long-term care patients (mainly female, median age 83.7 years, and 3-5 problems), 2004 monthly drug regimen reviews resulted in 173 recommendations for 104 patients. Some 93% of the recommendations were accepted. In decreasing rank order, recommendations were: for adverse drug reaction and interaction detection and resolution (47); needing nutritional or drug therapy (34); Omnibus Budget Reconciliation Act (OBRA) 1987 mandated psychotropic drug changes (32); recommended changes in dosing interval, dosage form, or administration technique (31); and lack of need, efficacy or drug duplications recommendations (29). The cost-benefit saving (ratio) from recommendation acceptance was $43,854 (4/1) or $241 per patient; the presumed cost-benefit lost by rejection was $60,825 (5.6/1) or $331 per patient. Geriatric long-term care patients appear to have numerous drug-related problems (DRPs) requiring unsolicited consultations. Acceptance of consultant pharmacist recommendations may influence cost of overall care. This article also appears as a chapter in `Geriatric drug therapy interventions', edited by the author (Haworth Press, 1997). (RH).
Accession NumberCPA-980806004 A
ClassmarkLLD: LF7:4Q: QDC: 7T

Data © Centre for Policy on Ageing

...from the Ageinfo database published by Centre for Policy on Ageing.
 

CPA home >> Ageinfo Database >> Last modified: Fri 21 Sep 2018, © CPA 2018 Queries to: webmaster@cpa.org.uk